Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell Lymphoma

PURPOSE: Axicabtagene ciloleucel (axi-cel) is a CD19-directed chimeric antigen receptor (CAR) T-cell therapy for relapsed or refractory diffuse large B-cell lymphoma. Bridging therapy may be required for lymphoma control during the manufacturing interval between collection of autologous T cells and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Int J Radiat Oncol Biol Phys
Hauptverfasser: Sim, Austin J., Jain, Michael D., Figura, Nicholas B., Chavez, Julio C., Shah, Bijal D., Khimani, Farhad, Lazaryan, Aleksandr, Krivenko, Gabriel, Davila, Marco L., Liu, Hien D., Falchook, Aaron D., Dahiya, Saurabh, Rapoport, Aaron P., Kim, Sungjune, Locke, Frederick L., Robinson, Timothy J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6872916/
https://ncbi.nlm.nih.gov/pubmed/31175906
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2019.05.065
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge